You are here: Industry Insights > Alzheimer

News List

Researchers define Alzheimer's-like brain disorder worldpharmanews
May 06, 2019
A brain disorder that mimics symptoms of Alzheimer's disease has been defined with recommended diagnostic criteria and guidelines for advancing future research on the condition.
Researchers define Alzheimer's-like brain disorder worldpharmanews
May 05, 2019
A brain disorder that mimics symptoms of Alzheimer's disease has been defined with recommended diagnostic criteria and guidelines for advancing future research on the condition.
Diabetes drug significantly reverses memory loss in Alzheimer’s disease europeanpharmaceuticalreview
April 30, 2019
A drug developed for diabetes could be used to treat Alzheimer’s after scientists discover it significantly reversed memory loss in mice through a triple method of action…
Advances in PET settle debate over spread of key protein in Alzheimer’s europeanpharmaceuticalreview
April 30, 2019
Advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer’s disease…
Nicotinamide riboside repairs features of Alzheimer’s disease europeanpharmaceuticalreview
April 30, 2019
Researchers have found that an NAD+ precursor helped mice with features of Alzheimer’s disease perform better on learning and memory tests…
After the Alzheimer's Crash, Should Biogen Turn to M&A to Bolster Its Pipeline? biospace
April 28, 2019
Earlier this week, Biogen reported out its first-quarter financial results, showing an 11% increase in revenues, hitting $3.5 billion. But in light of the company’s announcement in late March...
Agroceutical Products’ daffodils a boon to Alzheimer’s patients pharmaceutical-technology
April 23, 2019
Agroceutical Products’ daffodils a boon to Alzheimer’s patients...
Benzodiazepines associated with an increased risk of Alzheimer’s disease europeanpharmaceuticalreview
April 19, 2019
Current advice points to single or occasional use of the drug, and it is not recommended to be used for longer than four weeks…
Alzheimer’s disease patients often show psychotropic polypharmacy europeanpharmaceuticalreview
April 17, 2019
The results of the study were said to be concerning because previous research had linked psychotropic drug use among older people and patients with dementia to several adverse events…
More Alzheimer's Drug Trial Failures: Are Researchers on the Wrong Track? drugs
April 11, 2019
Amyloid beta has long been a prime suspect in Alzheimer's disease, since abnormal levels of the protein form disruptive plaques between patients' brain cells...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 16 17 Next page